GlaxoSmithKline announced on June 20 that it had released
... genomic profiling data for over 300 cancer cell lines via the National Cancer Institute’s cancer Bioinformatics Grid (caBIG) ...
The genomic data being shared by GSK through caBIGTM come from cell lines derived from a wide variety of tumors, including breast, prostate, lung and ovarian cancers. Researchers at academic institutions, small research facilities and non-profit organizations may benefit by not having to incur the prohibitive cost and time involved in identifying and cataloging each cell line. ...
Interested researchers can download this free data through caArray. GSKdata caArray, like all the tools in the caBIG suite, is free and open-source. ...
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
